EPSRC funding announced to tackle resistance to antibiotics
09 June 2021
A cross-disciplinary team from the Universities of Oxford, Ulster and UCL today announced major funding from EPSRC, part of UK Research and Innovation (UKRI), to tackle the growing challenge of Antimicrobial Resistance (AMR).
The new 5-year programme, “Beyond Antibiotics,” will start in October 2021 and bring together researchers from across the Physical and Life Sciences to develop new technology to improve both the diagnosis and treatment of bacterial infections.
Further reading: University of Oxford
Author(s): University of Oxford
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
